MEDNAX Inc
NYSE:MD

Watchlist Manager
MEDNAX Inc Logo
MEDNAX Inc
NYSE:MD
Watchlist
Price: 14.96 USD 1.42% Market Closed
Market Cap: 1.3B USD
Have any thoughts about
MEDNAX Inc?
Write Note

Intrinsic Value

The intrinsic value of one MD stock under the Base Case scenario is 23.48 USD. Compared to the current market price of 14.96 USD, MEDNAX Inc is Undervalued by 36%.

The Intrinsic Value is calculated as the average of DCF and Relative values:

MD Intrinsic Value
23.48 USD
Undervaluation 36%
Intrinsic Value
Price
Worst Case
Base Case
Best Case

Valuation Backtest
MEDNAX Inc

Backtest Intrinsic Value
Dive into the past to invest in the future

Uncover deeper insights with the Valuation Backtest. Learn how current stock valuations stack up against historical averages to gauge true investment potential.

Start backtest now and learn if your stock is truly undervalued or overvalued!

Run Backtest
Backtest Conclusion
Very Attractive
Current Valuation
+45%
Avg Valuation
-12%
Worst Valuation
-49%
Best Valuation
+45%

Stock is trading at its lowest valuation over the past 5 years.

Backtest Example
Register to View Results
Register to View Results

To access the results of this valuation backtest, please register an account with us. Registration is quick and gives you instant access to insights on 3 stocks per week for free.

Backtest Unavailable

The backtest for MD cannot be conducted due to limitations such as insufficient data or other constraints. Please select a different stock or adjust your settings.

Backtest In Progress...
Backtest In Progress...
How do you feel about MD?
Bearish
Neutral
Bullish

Fundamental Analysis

Company Quality
No Indicators Selected
Select Indicators

Select up to 3 indicators:

Insider Trading
0-3
Months
0-6
Months
0-12
Months
0-36
Months
No Periods Selected
Select Periods

Select up to 2 periods:

Investment Journal
AI Assistant
AI Assistant
Ask me anything about MEDNAX Inc

Provide an overview of the primary business activities
of MEDNAX Inc.

What unique competitive advantages
does MEDNAX Inc hold over its rivals?

What risks and challenges
does MEDNAX Inc face in the near future?

Has there been any significant insider trading activity
in MEDNAX Inc recently?

Summarize the latest earnings call
of MEDNAX Inc.

Is it considered overvalued or undervalued
based on the latest financial data?

Show all valuation multiples
for MEDNAX Inc.

Provide P/S
for MEDNAX Inc.

Provide P/E
for MEDNAX Inc.

Provide P/OCF
for MEDNAX Inc.

Provide P/FCFE
for MEDNAX Inc.

Provide P/B
for MEDNAX Inc.

Provide EV/S
for MEDNAX Inc.

Provide EV/GP
for MEDNAX Inc.

Provide EV/EBITDA
for MEDNAX Inc.

Provide EV/EBIT
for MEDNAX Inc.

Provide EV/OCF
for MEDNAX Inc.

Provide EV/FCFF
for MEDNAX Inc.

Provide EV/IC
for MEDNAX Inc.

Show me price targets
for MEDNAX Inc made by professional analysts.

What are the Revenue projections
for MEDNAX Inc?

How accurate were the past Revenue estimates
for MEDNAX Inc?

What are the Net Income projections
for MEDNAX Inc?

How accurate were the past Net Income estimates
for MEDNAX Inc?

What are the EPS projections
for MEDNAX Inc?

How accurate were the past EPS estimates
for MEDNAX Inc?

What are the EBIT projections
for MEDNAX Inc?

How accurate were the past EBIT estimates
for MEDNAX Inc?

Compare the revenue forecasts
for MEDNAX Inc with those of its competitors based on recent analyst estimates.

Compare the intrinsic valuations
of MEDNAX Inc and its key competitors using the latest financial data.

Compare historical revenue growth rates
of MEDNAX Inc against its competitors.

Analyze the profit margins
(gross, operating, and net) of MEDNAX Inc compared to its peers.

Compare the P/E ratios
of MEDNAX Inc against its peers.

Discuss the investment returns and shareholder value creation
comparing MEDNAX Inc with its peers.

Analyze the financial leverage
of MEDNAX Inc compared to its main competitors.

Show all profitability ratios
for MEDNAX Inc.

Provide ROE
for MEDNAX Inc.

Provide ROA
for MEDNAX Inc.

Provide ROIC
for MEDNAX Inc.

Provide ROCE
for MEDNAX Inc.

Provide Gross Margin
for MEDNAX Inc.

Provide Operating Margin
for MEDNAX Inc.

Provide Net Margin
for MEDNAX Inc.

Provide FCF Margin
for MEDNAX Inc.

Show all solvency ratios
for MEDNAX Inc.

Provide D/E Ratio
for MEDNAX Inc.

Provide D/A Ratio
for MEDNAX Inc.

Provide Interest Coverage Ratio
for MEDNAX Inc.

Provide Altman Z-Score Ratio
for MEDNAX Inc.

Provide Quick Ratio
for MEDNAX Inc.

Provide Current Ratio
for MEDNAX Inc.

Provide Cash Ratio
for MEDNAX Inc.

What is the historical Revenue growth
over the last 5 years for MEDNAX Inc?

What is the historical Net Income growth
over the last 5 years for MEDNAX Inc?

What is the current Free Cash Flow
of MEDNAX Inc?

Discuss the annual earnings per share (EPS)
trend over the past five years for MEDNAX Inc.

Financials
Annual
Quarterly
TTM
Annual
Quarterly
TTM

Balance Sheet Decomposition
MEDNAX Inc

Current Assets 528.2m
Cash & Short-Term Investments 220.5m
Receivables 288.1m
Other Current Assets 19.7m
Non-Current Assets 1.5B
PP&E 98.5m
Intangibles 1.3B
Other Non-Current Assets 198m
Current Liabilities 373.1m
Accounts Payable 47.4m
Accrued Liabilities 303.1m
Other Current Liabilities 22.6m
Non-Current Liabilities 971.3m
Long-Term Debt 607.4m
Other Non-Current Liabilities 363.9m
Efficiency

Earnings Waterfall
MEDNAX Inc

Revenue
2B USD
Operating Expenses
-1.8B USD
Operating Income
164.6m USD
Other Expenses
-418.5m USD
Net Income
-253.8m USD

Free Cash Flow Analysis
MEDNAX Inc

Last Value
3-Years Average
FCF Margin
Conversion Rate
Fundamental Scores

MD Profitability Score
Profitability Due Diligence

MEDNAX Inc's profitability score is 42/100. The higher the profitability score, the more profitable the company is.

Positive Free Cash Flow
Positive 3-Years Revenue Growth
ROIC is Increasing
Positive Revenue Growth Forecast
42/100
Profitability
Score

MEDNAX Inc's profitability score is 42/100. The higher the profitability score, the more profitable the company is.

MD Solvency Score
Solvency Due Diligence

MEDNAX Inc's solvency score is 48/100. The higher the solvency score, the more solvent the company is.

Long-Term Solvency
Low D/E
Short-Term Solvency
Positive Net Debt
48/100
Solvency
Score

MEDNAX Inc's solvency score is 48/100. The higher the solvency score, the more solvent the company is.

Wall St
Price Targets

MD Price Targets Summary
MEDNAX Inc

Wall Street analysts forecast MD stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for MD is 15.89 USD with a low forecast of 13.13 USD and a high forecast of 18.9 USD.

Lowest
Price Target
13.13 USD
12% Downside
Average
Price Target
15.89 USD
6% Upside
Highest
Price Target
18.9 USD
26% Upside
View Analyst Estimates
View Analyst Estimates
Want to learn more about Wall St estimates for MD?

Click here to dive deeper.

Dividends

MEDNAX Inc
does not pay dividends
Shareholder Yield

Current shareholder yield for MD is .

Shareholder yield represents the total return a company provides to its shareholders, calculated as the sum of dividend yield, buyback yield, and debt paydown yield. What is shareholder yield?

Shareholder Yield
Dividend Yield
No dividends
Buyback Yield
Lowest
Average
Highest
Debt Paydown Yield
Lowest
Average
Highest

Ownership

MD Insider Trading
Buy and sell transactions by insiders

Cumulative Transactions Amount
Period Sold Bought Net
3 Months
6 Months
9 Months
12 Months
Why is insider trading important?

MD News

Other Videos

Profile

MEDNAX Inc Logo
MEDNAX Inc

Country

United States of America

Industry

Health Care

Market Cap

1.3B USD

Dividend Yield

0%

Description

MEDNAX, Inc. engages in the provision of physician services. The company is headquartered in Sunrise, Florida and currently employs 2,725 full-time employees. The firm provides neonatal care, which provides clinical care to babies born prematurely or with complications within specific units at hospitals, primarily neonatal intensive care units (NICUs), through its network of affiliated neonatal physician subspecialists (neonatologists), neonatal nurse practitioners and other pediatric clinicians. The company offers maternal-fetal care, which provides inpatient and office-based clinical care to expectant mothers and their unborn babies through its affiliated maternal-fetal medicine subspecialists as well as obstetricians and other clinicians, such as maternal-fetal nurse practitioners and certified nurse mid-wives. The company provides other pediatric subspecialty care services, which includes other pediatric subspecialists, such as, pediatric hospitalists, pediatric surgeons, and pediatric ophthalmologists.

Contact

FLORIDA
Sunrise
1301 Concord Ter
+19543840175.0
www.mednax.com

IPO

1995-09-20

Employees

2 725

Officers

CEO & Director
Dr. James D. Swift M.D.
Executive VP, General Counsel & Secretary
Ms. Mary Ann E. Moore
Executive VP, Treasurer & CFO
Ms. Kasandra H. Rossi
Senior VP & Chief Accounting Officer
Mr. John C. Pepia
Senior VP & Chief Information Officer
Ms. Cheryl M. VanPatten
Senior Vice President of Administration & Managed Care
Mr. Daniel Patrick Corcoran
Show More
Senior VP of Finance, Strategy & Investor Relations
Mr. Charles W. Lynch C.F.A.
Senior VP, Chief Brand & Communications Officer
Ms. Meghan K. Lublin
Senior Vice President of People Services
Ms. Debra McRoberts
President of Regional Operations (Central)
Mr. Mike Ashford
Show Less

See Also

Discover More
What is the Intrinsic Value of one MD stock?

The intrinsic value of one MD stock under the Base Case scenario is 23.48 USD.

Is MD stock undervalued or overvalued?

Compared to the current market price of 14.96 USD, MEDNAX Inc is Undervalued by 36%.

Back to Top